speb/financial-data huggingface dataset:
Financial ratios for ALJXR.PA — annual report dated 2022-12-31
Total revenue: 15205319.148936171
Gross profit: 3363829.787234043
Operating income: -2812765.9574468085
Net income: -1285106.3829787234
Capital expenditures: 293617.02127659577
Operating cash flow: -5023404.255319149
Depreciation & amortization: 311702.1276595745
Net tangible assets: -5325531.914893617
Owner earnings: -1267021.2765957448
Buffett classification: The Gruesome
Stock price: 15.531914893617023
Shares outstanding: 58053021
Book value: -30851.063829787076
Market cap (USD): 901674581.4893618
Debt to equity: -243.8965517241392
Current ratio: 1.616325468424705
Quick ratio: 1.3293719639139485
Interest coverage ratio: -101.69230769230768
COGS to revenue (%): 77.8772825858812
Free cash flow (dilution-adjusted): -5381914.893617022
Buyback yield (%): 0
Retained earnings: -1285106.3829787234
Inventory turnover: 3.364873035066506
Receivables turnover: 8.37807737397421
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.66437484084543
FCF margin (%): -35.39494857622613
Rule of 40 score: -35.39494857622613
Financial ratios for ALJXR.PA — annual report dated 2023-12-31
Total revenue: 21978888.888888888
Gross profit: 5607777.777777778
Operating income: -1494444.4444444445
Net income: -2670000
Capital expenditures: 336666.6666666667
Operating cash flow: -4467777.777777778
Depreciation & amortization: 556666.6666666666
Net tangible assets: -9801111.11111111
Owner earnings: -2450000
Buffett classification: The Gruesome
Stock price: 0.6222222222222222
Shares outstanding: 58053021
Book value: 686666.6666666642
P/B ratio: 52.60467922330116
Market cap (USD): 36121879.733333334
Debt to equity: 18.690938511326927
Current ratio: 1.6491487211381481
Quick ratio: 1.3629790873046723
Interest coverage ratio: -24.454545454545457
COGS to revenue (%): 74.4856175117537
Free cash flow (dilution-adjusted): -4832222.222222222
Buyback yield (%): 0
Retained earnings: -2900000
Inventory turnover: 4.002716653083401
Receivables turnover: 3.401719690455718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.131826741996235
FCF margin (%): -21.98574389565745
Revenue growth (%): 44.54736973032641
Rule of 40 score: 22.56162583466896
Financial ratios for ALJXR.PA — annual report dated 2024-12-31
Total revenue: 32678125
Gross profit: 9027083.333333334
Operating income: 1093750
Net income: 1460416.6666666667
Capital expenditures: 195833.33333333334
Operating cash flow: 1072916.6666666667
Depreciation & amortization: 428125
Net tangible assets: -6472916.666666667
Owner earnings: 1692708.3333333335
Return on net tangible assets (%): -26.15062761506276
Capex to operating income (%): 17.904761904761905
Buffett classification: The Great
Stock price: 0.11458333333333334
P/E ratio: 4.554801932952924
Shares outstanding: 58053021
Book value: 5039583.333333332
P/B ratio: 1.3199322674658953
Market cap (USD): 6651908.656250001
Debt to equity: 1.661430343116991
Current ratio: 1.7545028142589116
Quick ratio: 1.4785178236397747
Effective tax rate (%): 17.188422917897224
Interest coverage ratio: 3.240740740740741
COGS to revenue (%): 72.375761053202
Free cash flow (dilution-adjusted): 1072916.6666666667
Buyback yield (%): 0
Inventory turnover: 7.717539089055065
Receivables turnover: 7.288801115241634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.665352606219885
FCF margin (%): 3.2832871123011698
Revenue growth (%): 48.67960416561347
Rule of 40 score: 51.962891277914636
Financial ratios for ALJXR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -6472916.666666667
Buffett classification: The Gruesome
Stock price: 0.11458333333333334
Shares outstanding: 58053021
Book value: 5039583.333333332
P/B ratio: 1.3199322674658953
Market cap (USD): 6651908.656250001
Debt to equity: 1.661430343116991
Current ratio: 1.7545028142589116
Quick ratio: 1.4785178236397747
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOPM.PA — annual report dated 2022-12-31
Total revenue: 885237.9787234042
Gross profit: -7116164.14893617
Operating income: -9317867.340425532
Net income: -245937.2340425532
Capital expenditures: 0
Depreciation & amortization: 174537.2340425532
Net tangible assets: 11688202.127659576
Owner earnings: -71400
Return on net tangible assets (%): -0.6108723926927588
Buffett classification: The Gruesome
Stock price: 1.8085106382978724
Shares outstanding: 19067385
Book value: 12533378.723404255
P/B ratio: 2.7513385957633476
Market cap (USD): 34483568.61702128
Debt to equity: 0.22098955164490128
Current ratio: 4.139478063370272
Quick ratio: 4.139478063370272
Interest coverage ratio: -75.1827922746781
COGS to revenue (%): 903.8701818010953
Buyback yield (%): 0
Retained earnings: -245937.2340425532
Receivables turnover: 1.7282048033628523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -60.802499992884584
Rule of 40 score: 0
Financial ratios for ALOPM.PA — annual report dated 2023-12-31
Total revenue: 1191299.4888888889
Gross profit: -7331208.3
Operating income: -11048590.9
Net income: -8989638.977777777
Capital expenditures: 0
Depreciation & amortization: 282263.77777777775
Net tangible assets: 2826257.5555555555
Owner earnings: -8707375.2
Return on net tangible assets (%): -308.0885244476028
Buffett classification: The Gruesome
Stock price: 2.011111111111111
Shares outstanding: 19067385
Book value: 4100778.444444444
P/B ratio: 9.351061110185965
Market cap (USD): 38346629.833333336
Debt to equity: 2.3915947801346986
Current ratio: 3.5022562809220372
Quick ratio: 3.5022562809220372
Interest coverage ratio: -67.81399675269675
COGS to revenue (%): 715.3959074420263
Buyback yield (%): 0
Retained earnings: -9246506.566666666
Receivables turnover: 1.0083814756997753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -79.42270895261179
Revenue growth (%): 34.573924472473934
Rule of 40 score: 34.573924472473934
Financial ratios for ALOPM.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7395833333333334
Shares outstanding: 19067385
Market cap (USD): 14101920.15625
Current ratio: 2.6877951615587907
Quick ratio: 2.6877951615587907
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOPM.PA — annual report dated 2024-12-31
Total revenue: 215666.6666666667
Gross profit: -6555730.260416667
Operating income: -8132376.729166667
Net income: -7510020.229166667
Capital expenditures: 0
Depreciation & amortization: 269200
Net tangible assets: -1572745.6145833335
Owner earnings: -7240820.229166667
Buffett classification: The Gruesome
Stock price: 0.7395833333333334
Shares outstanding: 19067385
Book value: -447279.88541666605
Market cap (USD): 14101920.15625
Debt to equity: -17.65459239273398
Current ratio: 2.6877951615587907
Quick ratio: 2.6877951615587907
Interest coverage ratio: -17.79217620082145
COGS to revenue (%): 3139.7512799459037
Buyback yield (%): 0
Retained earnings: -16178620.135416668
Receivables turnover: 0.3316859204116879
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -104.25540387550794
Revenue growth (%): -81.8965198358461
Rule of 40 score: -81.8965198358461
Financial ratios for ALOPM.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 10966235.294117648
Buffett classification: The Gruesome
Stock price: 0.35294117647058826
Shares outstanding: 19067385
Market cap (USD): 6729665.294117647
Quick ratio: 0
Buyback yield (%): 0
Retained earnings: 5070134.117647059
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSAF.PA — annual report dated 2021-12-31
Total revenue: 5182954.545454546
Gross profit: 2932954.5454545454
Operating income: -8614772.727272727
Net income: -7623863.636363637
Capital expenditures: 2223863.6363636362
Operating cash flow: -7111363.636363637
Depreciation & amortization: 987500
Net tangible assets: -1847727.2727272727
Owner earnings: -8860227.272727273
Buffett classification: The Gruesome
Shares outstanding: 181223
Book value: 452272.72727272846
Debt to equity: 22.26130653266326
Current ratio: 0.9116443658078072
Quick ratio: 0.5093442441667588
Interest coverage ratio: -11.88244514106583
COGS to revenue (%): 43.41153255864941
SG&A to revenue (%): 51.08528831396624
Free cash flow (dilution-adjusted): -9335227.272727273
Retained earnings: -7623863.636363637
Inventory turnover: 0.5442550852116548
Receivables turnover: 3.4088191330343802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -129.87836217234877
FCF margin (%): -180.11401008550757
Rule of 40 score: -180.11401008550757
Financial ratios for ALSAF.PA — annual report dated 2022-12-31
Total revenue: 6235106.382978723
Gross profit: 4177659.5744680855
Operating income: -6374468.085106383
Net income: -7409574.468085106
Capital expenditures: 912765.9574468086
Operating cash flow: -5818085.106382979
Depreciation & amortization: 1020212.7659574469
Net tangible assets: -3467021.276595745
Owner earnings: -7302127.659574469
Buffett classification: The Gruesome
Stock price: 826504.840425532
Shares outstanding: 181223
Book value: -1360638.2978723384
Market cap (USD): 149781686696.4362
Debt to equity: -7.906176700547315
Current ratio: 0.7435135352237128
Quick ratio: 0.38139609607197367
Interest coverage ratio: -14.132075471698112
COGS to revenue (%): 32.99778194847296
SG&A to revenue (%): 5.2380139907865555
Free cash flow (dilution-adjusted): -6730851.063829788
Buyback yield (%): 0
Retained earnings: -7409574.468085106
Inventory turnover: 0.4290150842945874
Receivables turnover: 2.475084459459459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -147.25976898500858
FCF margin (%): -107.95086162770859
Revenue growth (%): 20.300232778366063
Rule of 40 score: -87.65062884934252
Financial ratios for ALSAF.PA — annual report dated 2023-12-31
Total revenue: 6455555.555555555
Gross profit: 4803333.333333333
Operating income: -7022222.222222222
Net income: -228271111.1111111
Capital expenditures: 62222.22222222222
Operating cash flow: 71936666.66666667
Depreciation & amortization: 4801111.111111111
Net tangible assets: -224850000
Owner earnings: -223532222.2222222
Buffett classification: The Gruesome
Stock price: 3266.6666666666665
Shares outstanding: 181223
Book value: -224837777.7777778
Market cap (USD): 591995133.3333333
Debt to equity: -1.340250254504482
Current ratio: 0.030733736625065847
Quick ratio: 0.015183388740530816
Interest coverage ratio: -28.990825688073393
COGS to revenue (%): 25.593803786574874
SG&A to revenue (%): 4.509466437177282
Free cash flow (dilution-adjusted): 71831111.11111112
Buyback yield (%): 0
Retained earnings: -228271111.1111111
Inventory turnover: 0.34742990654205613
Receivables turnover: 2.7865707434052758
Capitalized R&D asset: 0
FCF margin (%): 1112.7022375215147
Revenue growth (%): 3.5356120495175185
Rule of 40 score: 1116.2378495710323
Financial ratios for ALSAF.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -8927083.333333334
Buffett classification: The Gruesome
Stock price: 7.500000000000001
Shares outstanding: 181223
Book value: -8772916.666666666
Market cap (USD): 1359172.5000000002
Debt to equity: -1.3996675374020424
Current ratio: 0.3896096664624979
Quick ratio: 0.20051227796647922
Buyback yield (%): 0
Retained earnings: -2009711458.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSAF.PA — annual report dated 2024-12-31
Total revenue: 5251041.666666667
Gross profit: 2760416.666666667
Operating income: -8171875
Net income: -2009711458.3333335
Capital expenditures: 5208.333333333334
Operating cash flow: -3403125
Depreciation & amortization: 835416.6666666667
Net tangible assets: -8927083.333333334
Owner earnings: -2008881250
Buffett classification: The Gruesome
Stock price: 7.500000000000001
Shares outstanding: 181223
Book value: -8772916.666666666
Market cap (USD): 1359172.5000000002
Debt to equity: -1.3996675374020424
Current ratio: 0.3896096664624979
Quick ratio: 0.20051227796647922
Interest coverage ratio: -0.0036978030006646146
COGS to revenue (%): 47.431065264828405
SG&A to revenue (%): 4.225352112676056
Free cash flow (dilution-adjusted): -3500000
Buyback yield (%): 0
Retained earnings: -2009711458.3333335
Inventory turnover: 0.7040636042402827
Receivables turnover: 1.5016383675901104
Capitalized R&D asset: 0
FCF margin (%): -66.65344177742512
Revenue growth (%): -18.65856282271944
Rule of 40 score: -85.31200460014455
Financial ratios for ALSAF.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -18594117.647058822
Buffett classification: The Gruesome
Stock price: 0.2823529411764706
Shares outstanding: 181223
Book value: -18472941.176470593
Market cap (USD): 51168.84705882353
Debt to equity: -0.9216660298051202
Current ratio: 0.19656213704994194
Quick ratio: 0.03888501742160279
Buyback yield (%): 0
Retained earnings: -5945882.352941177
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARM — annual report dated 2024-03-31
Total revenue: 4092405063.291139
Gross profit: 3897468354.4303794
Operating income: 148101265.8227848
Net income: 387341772.15189874
Capital expenditures: 116455696.20253164
Operating cash flow: 1379746835.443038
Depreciation & amortization: 205063291.1392405
Net tangible assets: 4453164556.962025
Owner earnings: 475949367.0886076
Return on net tangible assets (%): 10.687890847072202
Capex to operating income (%): 78.63247863247864
Buffett classification: The Gruesome
Stock price: 124.99
P/E ratio: 344.65470499279735
Shares outstanding: 1068078760
Book value: 6702531645.56962
P/B ratio: 19.917722328195655
Market cap (USD): 133499164212.4
Debt to equity: 0.04268177525967894
Current ratio: 2.788704318936877
Quick ratio: 2.788704318936877
Effective tax rate (%): -44.33962264150943
COGS to revenue (%): 4.763377667800804
R&D to revenue (%): 61.21249613362202
SG&A to revenue (%): 30.40519641200124
Free cash flow (dilution-adjusted): -113924050.6329112
Buyback yield (%): 0
Retained earnings: 3482278481.012658
Receivables turnover: 2.639183673469388
Capitalized R&D asset: 3874275604.329624
ROCI (R&D-adjusted, %): 7.626885763777228
Rosenberg metric: 0.5154010300870322
FCF margin (%): -2.783792143519946
Revenue growth (%): 23.734531588869835
Rule of 40 score: 20.95073944534989
Financial ratios for ARM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 143.01
Shares outstanding: 1068078760
Market cap (USD): 152745943467.59998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARM — quarterly report dated 2024-12-31
Total revenue: 1228750000
Gross profit: 1193750000
Operating income: 218750000
Net income: 315000000
Capital expenditures: 78750000
Operating cash flow: 528750000
Depreciation & amortization: 58750000
Net tangible assets: 5797500000
Owner earnings: 295000000
Return on net tangible assets (%): 5.088400172488142
Capex to operating income (%): 36
Buffett classification: The Good
Stock price: 123.36
P/E ratio: 104.56999669333334
Shares outstanding: 1068078760
Book value: 8023750000
P/B ratio: 16.42102456252999
Market cap (USD): 131758195833.6
Debt to equity: 0.04221841408319053
Current ratio: 4.9588100686498855
Quick ratio: 4.9588100686498855
Effective tax rate (%): 5.970149253731343
COGS to revenue (%): 2.8484231943031535
R&D to revenue (%): 54.221770091556465
SG&A to revenue (%): 25.127161749745675
Free cash flow (dilution-adjusted): 166250000
Buyback yield (%): 0
Retained earnings: 4166250000
Receivables turnover: 0.617462311557789
Capitalized R&D asset: 666250000
ROCI (R&D-adjusted, %): 6.503167790721438
FCF margin (%): 13.53001017293998
Rule of 40 score: 13.53001017293998
Financial ratios for ARM — quarterly report dated 2025-03-31
Total revenue: 1611688311.6883116
Gross profit: 1575324675.3246753
Operating income: 532467532.46753246
Net income: 272727272.72727275
Capital expenditures: 96103896.1038961
Operating cash flow: 335064935.064935
Depreciation & amortization: 63636363.63636363
Net tangible assets: 6581818181.818182
Owner earnings: 240259740.2597403
Return on net tangible assets (%): 3.6503551696921868
Capex to operating income (%): 18.048780487804876
Buffett classification: The Great
Stock price: 106.79
P/E ratio: 104.55511988203332
Shares outstanding: 1068078760
Book value: 8881818181.818182
P/B ratio: 12.84197992409826
Market cap (USD): 114060130780.40001
Debt to equity: 0.05205439391723936
Current ratio: 5.19913885898816
Quick ratio: 5.19913885898816
Effective tax rate (%): -45.83333333333333
COGS to revenue (%): 2.2562449637389204
R&D to revenue (%): 43.996776792908946
SG&A to revenue (%): 20.70910556003223
Free cash flow (dilution-adjusted): -16883116.88311687
Buyback yield (%): 0
Retained earnings: 4601298701.298701
Receivables turnover: 0.6538461538461539
Capitalized R&D asset: 1155478409.090909
ROCI (R&D-adjusted, %): 6.780781847635351
Rosenberg metric: 0.5727199629638654
FCF margin (%): -1.0475423045930694
Revenue growth (%): 31.164867685722204
Rule of 40 score: 30.117325381129135
Financial ratios for ARM — annual report dated 2025-03-31
Total revenue: 5203896103.896104
Gross profit: 5046753246.753246
Operating income: 1079220779.2207792
Net income: 1028571428.5714285
Capital expenditures: 284415584.4155844
Operating cash flow: 515584415.58441556
Depreciation & amortization: 237662337.66233766
Net tangible assets: 6581818181.818182
Owner earnings: 981818181.8181818
Return on net tangible assets (%): 14.917127071823202
Capex to operating income (%): 26.35379061371841
Buffett classification: The Good
Stock price: 106.79
P/E ratio: 110.89179381427779
Shares outstanding: 1068078760
Book value: 8881818181.818182
P/B ratio: 12.84197992409826
Market cap (USD): 114060130780.40001
Debt to equity: 0.05205439391723936
Current ratio: 5.19913885898816
Quick ratio: 5.19913885898816
Effective tax rate (%): -10
COGS to revenue (%): 3.019715497878712
R&D to revenue (%): 51.68455203394061
SG&A to revenue (%): 24.557025205889694
Free cash flow (dilution-adjusted): -859740259.7402596
Buyback yield (%): 0
Retained earnings: 4601298701.298701
Receivables turnover: 2.1111696522655428
Capitalized R&D asset: 4829595387.2662735
ROCI (R&D-adjusted, %): 10.319960698675217
Rosenberg metric: 0.45878477257961847
FCF margin (%): -16.521088095832294
Revenue growth (%): 27.159849120876032
Rule of 40 score: 10.638761025043738
Financial ratios for ARM — quarterly report dated 2025-06-30
Total revenue: 1442465753.4246576
Gross profit: 1401369863.0136986
Operating income: 156164383.56164384
Net income: 178082191.78082192
Capital expenditures: 210958904.10958904
Operating cash flow: 454794520.5479452
Depreciation & amortization: 82191780.82191782
Net tangible assets: 7010958904.10959
Owner earnings: 49315068.49315071
Return on net tangible assets (%): 0.7033997655334118
Capex to operating income (%): 135.08771929824562
Buffett classification: The Gruesome
Stock price: 161.74
P/E ratio: 225.5796861342839
Shares outstanding: 1068078760
Book value: 9598630136.986301
P/B ratio: 17.997470074061937
Market cap (USD): 172751058642.40002
Debt to equity: 0.0565149136577708
Current ratio: 4.988428158148506
Quick ratio: 4.988428158148506
Effective tax rate (%): 10.958904109589042
COGS to revenue (%): 2.849002849002849
R&D to revenue (%): 61.72839506172839
SG&A to revenue (%): 24.596391263057928
Free cash flow (dilution-adjusted): -95890410.95890409
Buyback yield (%): 0
Retained earnings: 5031506849.315068
Receivables turnover: 0.4893122676579926
Capitalized R&D asset: 1585364367.9950187
ROCI (R&D-adjusted, %): 2.2349971951380527
Rosenberg metric: -0.24532088915650566
FCF margin (%): -6.647673314339979
Revenue growth (%): -10.499707482918097
Rule of 40 score: -17.147380797258077
Financial ratios for ARM — quarterly report dated 2025-09-30
Total revenue: 1533783783.783784
Gross profit: 1494594594.5945947
Operating income: 220270270.27027026
Net income: 321621621.6216216
Capital expenditures: 186486486.4864865
Operating cash flow: 766216216.2162162
Depreciation & amortization: 74324324.32432432
Net tangible assets: 7482432432.432432
Owner earnings: 209459459.45945942
Return on net tangible assets (%): 2.7993498284269456
Capex to operating income (%): 84.66257668711657
Buffett classification: The Gruesome
Stock price: 141.49
P/E ratio: 138.97199158639197
Shares outstanding: 1068078760
Book value: 10009459459.45946
P/B ratio: 15.09796451691319
Market cap (USD): 151122463752.40002
Debt to equity: 0.05535304441744296
Current ratio: 5.59375
Quick ratio: 5.59375
Effective tax rate (%): 21.192052980132452
COGS to revenue (%): 2.555066079295154
R&D to revenue (%): 60.88105726872246
SG&A to revenue (%): 22.202643171806162
Free cash flow (dilution-adjusted): 218918918.9189189
Buyback yield (%): 0
Retained earnings: 5285135135.135136
Receivables turnover: 0.642695356738392
Capitalized R&D asset: 1764359126.2495372
ROCI (R&D-adjusted, %): 2.2785540967770803
Rosenberg metric: 0.1046985446985449
FCF margin (%): 14.273127753303964
Revenue growth (%): 6.330689664023002
Rule of 40 score: 20.603817417326965
Financial ratios for ARM — quarterly report dated 2025-12-31
Total revenue: 1678378378.3783784
Gross profit: 1637837837.837838
Operating income: 258108108.1081081
Net income: 301351351.3513514
Capital expenditures: 241891891.8918919
Operating cash flow: 493243243.2432433
Depreciation & amortization: 85135135.13513513
Net tangible assets: 8017567567.567568
Owner earnings: 144594594.5945946
Return on net tangible assets (%): 1.803472105174448
Capex to operating income (%): 93.717277486911
Buffett classification: The Gruesome
Stock price: 109.31
P/E ratio: 108.7293712211218
Shares outstanding: 1068078760
Book value: 10537837837.837837
P/B ratio: 11.07928315582765
Market cap (USD): 116751689255.6
Debt to equity: 0.05911772249294692
Current ratio: 5.426679280983917
Quick ratio: 5.426679280983917
Effective tax rate (%): 2.1929824561403506
COGS to revenue (%): 2.4154589371980677
R&D to revenue (%): 59.33977455716586
SG&A to revenue (%): 22.866344605475042
Free cash flow (dilution-adjusted): -140540540.54054052
Buyback yield (%): 0
Retained earnings: 5586486486.486486
Receivables turnover: 0.6176031824962704
Capitalized R&D asset: 1915416697.5194373
ROCI (R&D-adjusted, %): 2.205355838051838
Rosenberg metric: 0.15340086830680172
FCF margin (%): -8.373590982286633
Revenue growth (%): 9.427312775330387
Rule of 40 score: 1.0537217930437546
Financial ratios for ARTL — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 245.97
Shares outstanding: 3485540
Market cap (USD): 857338273.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTL — annual report dated 2022-12-31
Total revenue: 0
Operating income: -10287000
Net income: -10083000
Capital expenditures: 0
Operating cash flow: -8008000
Net tangible assets: 17364000
Owner earnings: -10083000
Return on net tangible assets (%): -58.06841741534209
Buffett classification: The Gruesome
Stock price: 52.02
Shares outstanding: 3485540
Book value: 19403000
P/B ratio: 9.344832799051693
Market cap (USD): 181317790.8
Debt to equity: 0.0032469205792918622
Current ratio: 18.35871743486974
Quick ratio: 18.35871743486974
Interest coverage ratio: -2057.4
Free cash flow (dilution-adjusted): -10466000
Buyback yield (%): 0
Retained earnings: -31021000
Capitalized R&D asset: 4324000
ROCI (R&D-adjusted, %): -31.17614035087719
Rule of 40 score: 0
Financial ratios for ARTL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -9930000
Net income: -9289000
Capital expenditures: 0
Operating cash flow: -8207000
Net tangible assets: 9713000
Owner earnings: -9289000
Return on net tangible assets (%): -95.63471635951817
Buffett classification: The Gruesome
Stock price: 25.2
Shares outstanding: 3485540
Book value: 11752000
P/B ratio: 7.47409870660313
Market cap (USD): 87835608
Debt to equity: 0.0019571136827773996
Current ratio: 8.505034856700233
Quick ratio: 8.505034856700233
Free cash flow (dilution-adjusted): -9227000
Buyback yield (%): 0
Retained earnings: -40310000
Capitalized R&D asset: 8593080
ROCI (R&D-adjusted, %): -37.22767371767523
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.16
Shares outstanding: 3485540
Market cap (USD): 70268486.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -10108000
Net income: -9826000
Capital expenditures: 0
Operating cash flow: -8350000
Net tangible assets: 818000
Owner earnings: -9826000
Return on net tangible assets (%): -1201.2224938875306
Buffett classification: The Gruesome
Stock price: 19.08
Shares outstanding: 3485540
Book value: 2857000
P/B ratio: 23.277599999999996
Market cap (USD): 66504103.199999996
Debt to equity: 0.03640182009100455
Current ratio: 1.443002257336343
Quick ratio: 1.443002257336343
Free cash flow (dilution-adjusted): -9168000
Buyback yield (%): 0
Retained earnings: -50136000
Capitalized R&D asset: 11236240
ROCI (R&D-adjusted, %): -66.74556190734423
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.08
Shares outstanding: 3485540
Market cap (USD): 66504103.199999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2379000
Net income: -2372000
Capital expenditures: 0
Operating cash flow: -1597000
Net tangible assets: -1387000
Owner earnings: -2372000
Buffett classification: The Gruesome
Stock price: 15.75
Shares outstanding: 3485540
Book value: 652000
P/B ratio: 84.19824386503068
Market cap (USD): 54897255
Debt to equity: 0.14570552147239263
Current ratio: 0.492867332382311
Quick ratio: 0.492867332382311
Free cash flow (dilution-adjusted): -1789000
Buyback yield (%): 0
Retained earnings: -52508000
Capitalized R&D asset: 1384000
ROCI (R&D-adjusted, %): -69.51471758154335
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -3150000
Net income: -3221000
Capital expenditures: 0
Operating cash flow: -514000
Net tangible assets: -3445000
Owner earnings: -3221000
Buffett classification: The Gruesome
Stock price: 39.81
Shares outstanding: 3485540
Book value: -1406000
Market cap (USD): 138759347.4
Debt to equity: -0.6244665718349929
Current ratio: 0.3909313725490196
Quick ratio: 0.3909313725490196
Interest coverage ratio: -43.75
Free cash flow (dilution-adjusted): -664000
Buyback yield (%): 0
Retained earnings: -55729000
Capitalized R&D asset: 2798280
ROCI (R&D-adjusted, %): -163.79358128706832
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -3089000
Net income: -3120000
Capital expenditures: 0
Operating cash flow: -3498000
Net tangible assets: -2672000
Owner earnings: -3120000
Buffett classification: The Gruesome
Stock price: 13.77
Shares outstanding: 3485540
Book value: -633000
Market cap (USD): 47995885.8
Debt to equity: -1.5071090047393365
Current ratio: 0.37592592592592594
Quick ratio: 0.37592592592592594
Interest coverage ratio: -27.82882882882883
Free cash flow (dilution-adjusted): -3930000
Buyback yield (%): 0
Retained earnings: -58849000
Capitalized R&D asset: 2985290
ROCI (R&D-adjusted, %): -138.9463651981992
Rule of 40 score: 0
Financial ratios for ARTL — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2786000
Net income: -4166000
Capital expenditures: 0
Operating cash flow: -2911000
Net tangible assets: -3311000
Owner earnings: -4166000
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 3485540
Book value: -1272000
Market cap (USD): 12757076.4
Debt to equity: -0.5330188679245284
Current ratio: 0.1718595450049456
Quick ratio: 0.1718595450049456
Interest coverage ratio: -29.638297872340427
Free cash flow (dilution-adjusted): -3279000
Buyback yield (%): 0
Retained earnings: -63015000
Capitalized R&D asset: 2364680
ROCI (R&D-adjusted, %): -288.7930009747284
Rule of 40 score: 0
Financial ratios for ARTL — annual report dated 2025-12-31
Total revenue: 0
Operating income: -11404000
Net income: -12879000
Capital expenditures: 0
Operating cash flow: -8520000
Net tangible assets: -3311000
Owner earnings: -12879000
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 3485540
Book value: -1272000
Market cap (USD): 12757076.4
Debt to equity: -0.5330188679245284
Current ratio: 0.1718595450049456
Quick ratio: 0.1718595450049456
Interest coverage ratio: -41.16967509025271
Free cash flow (dilution-adjusted): -9662000
Buyback yield (%): 0
Retained earnings: -63015000
Capitalized R&D asset: 11317990
ROCI (R&D-adjusted, %): -115.98026400026204
Rule of 40 score: 0
Financial ratios for BEP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.33
Shares outstanding: 303275965
Market cap (USD): 8895084053.449999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEP — annual report dated 2022-12-31
Total revenue: 3463970588.235294
Gross profit: 2409558823.529412
Operating income: 1051470588.235294
Net income: 101470588.2352941
Capital expenditures: 1610294117.6470587
Operating cash flow: 1258088235.2941175
Depreciation & amortization: 1175000000
Net tangible assets: 2294852941.1764703
Owner earnings: -333823529.4117646
Return on net tangible assets (%): -14.54661967318167
Capex to operating income (%): 153.14685314685318
Buffett classification: The Gruesome
Stock price: 21.56
P/E ratio: 64.43867054597102
Shares outstanding: 303275965
Book value: 19327941176.470585
P/B ratio: 0.338299343199574
Market cap (USD): 6538629805.4
Debt to equity: 0.9666362322148674
Current ratio: 0.8462472182884888
Quick ratio: 0.8377503540360105
Effective tax rate (%): -1.4705882352941175
Interest coverage ratio: 1.1683006535947713
COGS to revenue (%): 30.75780089153046
SG&A to revenue (%): 5.158140522182127
Free cash flow (dilution-adjusted): -352205882.35294116
Buyback yield (%): 2.8338371059641827
Inventory turnover: 34.5
Receivables turnover: 4.157987643424537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.416846944294213
FCF margin (%): -10.167692634260241
Rule of 40 score: -10.167692634260241
Financial ratios for BEP — annual report dated 2023-12-31
Total revenue: 3816666666.6666665
Gross profit: 2352272727.272727
Operating income: 785606060.6060606
Net income: 466666666.6666666
Capital expenditures: 2128030303.030303
Operating cash flow: 1412878787.8787878
Depreciation & amortization: 1411363636.3636363
Net tangible assets: 2093939393.9393938
Owner earnings: -250000000
Return on net tangible assets (%): -11.939218523878438
Capex to operating income (%): 270.87753134040497
Buffett classification: The Gruesome
Stock price: 23.51
P/E ratio: 15.278609865321432
Shares outstanding: 303275965
Book value: 22711363636.36364
P/B ratio: 0.3139405476179325
Market cap (USD): 7130017937.150001
Debt to equity: 1.0163781313586175
Current ratio: 0.5735257526747948
Quick ratio: 0.5597163473500871
Effective tax rate (%): -8.45070422535211
Interest coverage ratio: 0.6373693915181315
COGS to revenue (%): 38.58674077014689
SG&A to revenue (%): 4.069075029773719
Free cash flow (dilution-adjusted): -715151515.1515151
Buyback yield (%): 0.4568818460613678
Inventory turnover: 17.513513513513512
Receivables turnover: 1.9984133280444267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5229842855044795
FCF margin (%): -18.737594283445812
Revenue growth (%): 10.18184391141301
Rule of 40 score: -8.555750372032803
Financial ratios for BEP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.57
Shares outstanding: 303275965
Market cap (USD): 6541662565.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEP — annual report dated 2024-12-31
Total revenue: 4109090909.0909095
Gross profit: 2304895104.895105
Operating income: 756643356.6433567
Net income: -6293706.293706294
Capital expenditures: 2610489510.4895105
Operating cash flow: 890909090.909091
Depreciation & amortization: 1405594405.5944057
Net tangible assets: -836363636.3636364
Owner earnings: -1211188811.188811
Capex to operating income (%): 345.00924214417745
Buffett classification: The Gruesome
Stock price: 21.57
Shares outstanding: 303275965
Book value: 25493706293.70629
P/B ratio: 0.2565991186093236
Market cap (USD): 6541662565.05
Debt to equity: 0.9750932631116964
Current ratio: 0.6065911431513903
Quick ratio: 0.5960178510127017
Interest coverage ratio: 0.5442655935613683
COGS to revenue (%): 43.907420013614704
Free cash flow (dilution-adjusted): -1719580419.5804195
Buyback yield (%): 1.9455715730845633
Inventory turnover: 16.753246753246753
Receivables turnover: 2.586267605633803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3483874183739595
FCF margin (%): -41.84819605173587
Revenue growth (%): 7.661770543866628
Rule of 40 score: -34.18642550786924
Financial ratios for BEP — quarterly report dated 2025-03-31
Total revenue: 1104895104.895105
Gross profit: 632867132.8671329
Operating income: 190909090.9090909
Net income: -65034965.03496504
Capital expenditures: 1081118881.1188812
Operating cash flow: 270629370.6293706
Depreciation & amortization: 407692307.6923077
Net tangible assets: -1130069930.06993
Owner earnings: -738461538.4615386
Capex to operating income (%): 566.3003663003664
Buffett classification: The Gruesome
Stock price: 21.33
Shares outstanding: 303275965
Book value: 23506293706.29371
P/B ratio: 0.2751976306548908
Market cap (USD): 6468876333.45
Debt to equity: 1.0578627952638782
Current ratio: 0.5086971748774224
Quick ratio: 0.5006420733130984
Interest coverage ratio: 0.44827586206896547
COGS to revenue (%): 42.721518987341774
Free cash flow (dilution-adjusted): -810489510.4895105
Buyback yield (%): 0.291876330723564
Inventory turnover: 4.891304347826087
Receivables turnover: 0.6394172399838122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.34934609576945713
FCF margin (%): -73.35443037974684
Rule of 40 score: -73.35443037974684
Financial ratios for BEP — quarterly report dated 2025-06-30
Total revenue: 1235036496.350365
Gross profit: 724817518.2481751
Operating income: 239416058.39416057
Net income: 72992700.729927
Capital expenditures: 1078832116.788321
Operating cash flow: 276642335.76642334
Depreciation & amortization: 444525547.44525546
Net tangible assets: -1584671532.8467152
Owner earnings: -561313868.6131386
Capex to operating income (%): 450.60975609756093
Buffett classification: The Gruesome
Stock price: 24.94
P/E ratio: 25.905681292317503
Shares outstanding: 303275965
Book value: 24326277372.262764
P/B ratio: 0.31092725168563046
Market cap (USD): 7563702567.1
Debt to equity: 1.1345455636570951
Current ratio: 0.44104186677213403
Quick ratio: 0.4318323069099949
Interest coverage ratio: 0.5256410256410257
COGS to revenue (%): 41.31205673758865
Free cash flow (dilution-adjusted): -802189781.0218978
Buyback yield (%): 0.06755274953988467
Inventory turnover: 4.288343558282208
Receivables turnover: 0.6086330935251799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4054287903883712
FCF margin (%): -64.95271867612293
Revenue growth (%): 11.778619606393788
Rule of 40 score: -53.17409906972914
Financial ratios for BEP — quarterly report dated 2025-09-30
Total revenue: 1148201438.848921
Gross profit: 629496402.877698
Operating income: 148920863.30935252
Net income: 30215827.338129498
Capital expenditures: 1262589928.057554
Operating cash flow: 277697841.7266187
Depreciation & amortization: 439568345.323741
Net tangible assets: -1511510791.3669066
Owner earnings: -792805755.3956835
Capex to operating income (%): 847.8260869565219
Buffett classification: The Gruesome
Stock price: 25.21
P/E ratio: 200.28486916514137
Shares outstanding: 303275965
Book value: 23628776978.417274
P/B ratio: 0.3235710034689288
Market cap (USD): 7645587077.650001
Debt to equity: 1.0953294361222747
Current ratio: 0.582108378207927
Quick ratio: 0.576286809295105
Interest coverage ratio: 0.3532423208191126
COGS to revenue (%): 45.175438596491226
Free cash flow (dilution-adjusted): -984892086.3309354
Buyback yield (%): 0
Inventory turnover: 6.008333333333333
Receivables turnover: 0.5917686318131258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.26644355772943745
FCF margin (%): -85.77694235588972
Revenue growth (%): -7.030970967906507
Rule of 40 score: -92.80791332379623
Financial ratios for BEP — annual report dated 2025-12-31
Total revenue: 4676642335.766423
Gross profit: 2557664233.576642
Operating income: 624817518.2481751
Net income: 519708029.19708025
Capital expenditures: 4808029197.080292
Operating cash flow: 837226277.3722627
Depreciation & amortization: 1770072992.7007298
Net tangible assets: -1032846715.3284671
Owner earnings: -2518248175.182482
Capex to operating income (%): 769.5093457943925
Buffett classification: The Gruesome
Stock price: 26.36
P/E ratio: 15.382395476457866
Shares outstanding: 303275965
Book value: 25528467153.284668
P/B ratio: 0.31315450275170126
Market cap (USD): 7994354437.4
Debt to equity: 1.023531766455081
Current ratio: 0.5667803484192091
Quick ratio: 0.5586229145543368
Effective tax rate (%): -626.5306122448981
Interest coverage ratio: 0.3483923483923484
COGS to revenue (%): 45.30981738723271
Free cash flow (dilution-adjusted): -3970802919.708029
Buyback yield (%): 0.31043805278474207
Inventory turnover: 16.401129943502827
Receivables turnover: 2.2808828764684943
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.111645000844123
FCF margin (%): -84.90713282347431
Revenue growth (%): 13.81209224210321
Rule of 40 score: -71.09504058137111
Financial ratios for BEP — quarterly report dated 2025-12-31
Total revenue: 1123357664.2335765
Gross profit: 533576642.3357664
Operating income: 35036496.35036496
Net income: 494890510.94890505
Capital expenditures: 1319708029.1970801
Operating cash flow: -3649635.03649635
Depreciation & amortization: 454014598.54014593
Net tangible assets: -1032846715.3284671
Owner earnings: -370802919.70802915
Capex to operating income (%): 3766.6666666666665
Buffett classification: The Gruesome
Stock price: 26.36
P/E ratio: 14.996985967713137
Shares outstanding: 303275965
Book value: 25528467153.284668
P/B ratio: 0.31315450275170126
Market cap (USD): 7994354437.4
Debt to equity: 1.023531766455081
Current ratio: 0.5667803484192091
Quick ratio: 0.5586229145543368
Effective tax rate (%): -64.16464891041163
Interest coverage ratio: 0.07523510971786834
COGS to revenue (%): 52.501624431449
Free cash flow (dilution-adjusted): -1323357664.2335765
Buyback yield (%): 0
Inventory turnover: 4.56497175141243
Receivables turnover: 0.5478818084727661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.06233523369219381
FCF margin (%): -117.80376868096167
Revenue growth (%): -2.1637122002085767
Rule of 40 score: -119.96748088117025
Financial ratios for BGMS — annual report dated 2021-12-31
Net income: -4426139.0887290165
Capital expenditures: 6474.820143884892
Owner earnings: -4432613.908872901
Buffett classification: The Gruesome
Stock price: 6760.55
Shares outstanding: 5519456
Market cap (USD): 37314558260.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGMS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -6257013.574660634
Net income: -4795927.601809955
Capital expenditures: 1583.710407239819
Operating cash flow: -4711990.9502262445
Depreciation & amortization: 7239.819004524887
Net tangible assets: 4622850.678733032
Owner earnings: -4790271.49321267
Return on net tangible assets (%): -103.62159252190084
Buffett classification: The Gruesome
Stock price: 1164.41
Shares outstanding: 5519456
Book value: 4622850.678733031
P/B ratio: 1390.2481839888026
Market cap (USD): 6426909760.96
Debt to equity: 0.005187686585425537
Current ratio: 3.250033284516044
Quick ratio: 3.250033284516044
Free cash flow (dilution-adjusted): -5054298.642533937
Buyback yield (%): 0
Retained earnings: -91793438.91402715
Receivables turnover: 0
Capitalized R&D asset: 4586877.828054299
ROCI (R&D-adjusted, %): -34.645823634626225
Rule of 40 score: 0
Financial ratios for BGMS — annual report dated 2023-12-31
Total revenue: 91106.29067245118
Operating income: -5521258.1344902385
Net income: -4892624.728850325
Capital expenditures: 1301.518438177874
Operating cash flow: -3495010.8459869847
Depreciation & amortization: 6724.511930585682
Net tangible assets: 131670.2819956616
Owner earnings: -4887201.735357917
Return on net tangible assets (%): -3711.69686985173
Buffett classification: The Gruesome
Stock price: 309.35
Shares outstanding: 5519456
Book value: 131670.28199566156
P/B ratio: 12967.570872645805
Market cap (USD): 1707443713.6000001
Debt to equity: 0.060955518945634286
Current ratio: 0.912143119715721
Quick ratio: 0.912143119715721
COGS to revenue (%): 0
R&D to revenue (%): 4560.714285714285
SG&A to revenue (%): 1599.5238095238096
Free cash flow (dilution-adjusted): -3815835.1409978303
Buyback yield (%): 0
Retained earnings: -92902819.95661604
Receivables turnover: 0.11275167785234899
Capitalized R&D asset: 7228305.758679243
ROCI (R&D-adjusted, %): -58.09108484656209
FCF margin (%): -4188.333333333333
Rule of 40 score: -4188.333333333333
Financial ratios for BGMS — quarterly report dated 2024-09-30
Gross profit: 2427.1844660194174
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 114.7
Shares outstanding: 5519456
Market cap (USD): 633081603.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGMS — annual report dated 2024-12-31
Total revenue: 9641.255605381166
Gross profit: 9641.255605381166
Operating income: -2691479.8206278025
Net income: -2513901.34529148
Capital expenditures: 0
Operating cash flow: -1791479.8206278028
Depreciation & amortization: 1345.2914798206277
Net tangible assets: -487443.94618834084
Owner earnings: -2512556.053811659
Buffett classification: The Gruesome
Stock price: 44.03
Shares outstanding: 5519456
Book value: -487443.9461883408
Market cap (USD): 243021647.68
Debt to equity: 0
Current ratio: 0.5861518825781749
Quick ratio: 0.5861518825781749
COGS to revenue (%): 0
R&D to revenue (%): 15476.744186046511
SG&A to revenue (%): 12539.53488372093
Free cash flow (dilution-adjusted): -1924215.2466367714
Buyback yield (%): 0
Retained earnings: -98541255.60538116
Capitalized R&D asset: 5789737.55092715
ROCI (R&D-adjusted, %): -86.95677130316459
FCF margin (%): -19958.13953488372
Revenue growth (%): -89.41757420456972
Rule of 40 score: -20047.55710908829
Financial ratios for BGMS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.03
Shares outstanding: 5519456
Market cap (USD): 243021647.68
Buyback yield (%): 0
Capitalized R&D asset: 197309.41704035873
Rule of 40 score: 0
Financial ratios for BGMS — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -951241.5349887133
Net income: -18284.424379232507
Capital expenditures: 0
Operating cash flow: -732957.1106094809
Depreciation & amortization: 0
Net tangible assets: 691196.388261851
Owner earnings: -18284.424379232507
Return on net tangible assets (%): -2.6453298497713913
Buffett classification: The Gruesome
Stock price: 32.44
Shares outstanding: 5519456
Book value: 691196.3882618512
P/B ratio: 259.04526655623766
Market cap (USD): 179051152.64
Debt to equity: 0.0029392553886348786
Current ratio: 5.601809954751132
Quick ratio: 5.601809954751132
Free cash flow (dilution-adjusted): -1109029.3453724605
Buyback yield (%): 0
Retained earnings: -99426862.30248308
Capitalized R&D asset: 317750.3568211036
ROCI (R&D-adjusted, %): -88.36087449521997
Rule of 40 score: 0
Financial ratios for BGMS — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -311347.5177304964
Net income: -311583.92434988177
Capital expenditures: 0
Operating cash flow: -249645.39007092197
Depreciation & amortization: 236.40661938534276
Net tangible assets: 858392.4349881796
Owner earnings: -311347.5177304964
Return on net tangible assets (%): -36.27099972459377
Buffett classification: The Gruesome
Stock price: 4.95
Shares outstanding: 5519456
Book value: 858392.4349881796
P/B ratio: 31.828457575323608
Market cap (USD): 27321307.2
Debt to equity: 0.002754062241806665
Current ratio: 5.7671052631578945
Quick ratio: 5.7671052631578945
Free cash flow (dilution-adjusted): -251300.23640661937
Buyback yield (%): 0
Retained earnings: -104439479.90543734
Receivables turnover: 0
Capitalized R&D asset: 205508.29950224404
ROCI (R&D-adjusted, %): -40.163685311410205
Rule of 40 score: 0
Financial ratios for BGMS — quarterly report dated 2025-09-30
Total revenue: 19239.904988123515
Gross profit: 4038.004750593824
Operating income: -235629.4536817102
Net income: -234679.3349168646
Capital expenditures: 0
Operating cash flow: -103087.88598574822
Depreciation & amortization: 0
Net tangible assets: 1312589.0736342042
Owner earnings: -234679.3349168646
Return on net tangible assets (%): -17.879116901918206
Buffett classification: The Gruesome
Stock price: 4.94
Shares outstanding: 5519456
Book value: 1685510.6888361047
P/B ratio: 16.176766377452086
Market cap (USD): 27266112.64
Debt to equity: 0.0007046223224351746
Current ratio: 6.431137724550898
Quick ratio: 5.065868263473053
COGS to revenue (%): 79.01234567901236
R&D to revenue (%): 6.172839506172839
SG&A to revenue (%): 1239.5061728395062
Free cash flow (dilution-adjusted): -104513.06413301663
Buyback yield (%): 0
Retained earnings: -105525178.14726841
Inventory turnover: 0.046783625730994156
Receivables turnover: 0.11172413793103447
Capitalized R&D asset: 73190.83967859409
ROCI (R&D-adjusted, %): -17.03639076018555
FCF margin (%): -543.2098765432099
Rule of 40 score: -543.2098765432099
Financial ratios for BGMS — quarterly report dated 2025-12-31
Total revenue: 17239.17037037037
Gross profit: -117328.73086419754
Operating income: -414365.7679012346
Net income: -150864.1975308642
Capital expenditures: 0
Operating cash flow: -8148.148148148149
Depreciation & amortization: 987.6543209876544
Net tangible assets: 1301728.3950617285
Owner earnings: -149876.54320987657
Return on net tangible assets (%): -11.513657056145677
Buffett classification: The Gruesome
Stock price: 1.48
Shares outstanding: 5519456
Book value: 1689382.7160493827
P/B ratio: 4.835372590470623
Market cap (USD): 8168794.88
Debt to equity: 0.0002923121894182988
Current ratio: 4.696696696696697
Quick ratio: 3.6576576576576585
COGS to revenue (%): 780.5938356862865
R&D to revenue (%): -67.31726656377151
SG&A to revenue (%): 1790.352834142859
Free cash flow (dilution-adjusted): -169876.54320987655
Buyback yield (%): 0
Retained earnings: -112200246.91358025
Inventory turnover: 0.39378612716763
Receivables turnover: 0.055543866348448684
Capitalized R&D asset: -5504.249267039652
ROCI (R&D-adjusted, %): -25.368090680537485
Rosenberg metric: -102.19079138765434
FCF margin (%): -985.4101999122296
Revenue growth (%): -10.398879926840413
Rule of 40 score: -995.80907983907
Financial ratios for BGMS — annual report dated 2025-12-31
Total revenue: 19335.82716049383
Gross profit: -117328.73086419754
Operating income: -414365.7679012346
Net income: -740246.913580247
Capital expenditures: 0
Operating cash flow: -1177777.7777777778
Depreciation & amortization: 1234.567901234568
Net tangible assets: 1301728.3950617285
Owner earnings: -739012.3456790124
Return on net tangible assets (%): -56.77162367223064
Buffett classification: The Gruesome
Stock price: 1.48
Shares outstanding: 5519456
Book value: 1689382.7160493827
P/B ratio: 4.835372590470623
Market cap (USD): 8168794.88
Debt to equity: 0.0002923121894182988
Current ratio: 4.696696696696697
Quick ratio: 3.6576576576576585
COGS to revenue (%): 777.6774643372947
R&D to revenue (%): 1082.874367418762
SG&A to revenue (%): 9854.412138408708
Free cash flow (dilution-adjusted): -1754074.0740740742
Buyback yield (%): 0
Retained earnings: -112200246.91358025
Inventory turnover: 0.44002890173410397
Receivables turnover: 0.062299204455051715
Capitalized R&D asset: 2580307.0810970953
ROCI (R&D-adjusted, %): -50.491317104256225
Rosenberg metric: -0.08509183165354187
FCF margin (%): -9071.626776111892
Revenue growth (%): 100.55299799023834
Rule of 40 score: -8971.073778121654
Financial ratios for BNKR.L — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.014305555555555556
Shares outstanding: 920028108
Market cap (USD): 13161513.211666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0